%0 Journal Article
%T Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review
%A Kenneth M. Borow
%A Krishnaswami Vijayaraghavan
%A R. Preston Mason
%J Archive of "Cardiorenal Medicine".
%D 2017
%R 10.1159/000479391
%X Patients with end-stage renal disease on hemodialysis have excess cardiovascular disease (CVD) burden with substantially increased CV event rates compared with the general population
%K Atherosclerosis
%K Cardiovascular disease
%K Eicosapentaenoic acid
%K End-stage renal disease
%K Icosapent ethyl
%K Inflammation
%K Oxidative stress
%K Omega-3 fatty acids
%K Hemodialysis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757596/